News
-
-
-
-
PRESS RELEASE
Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I
Applied DNA Sciences expands Linea Mpox Virus 1.0 Assay to detect mpox clade I and clade Ib in addition to clade II with 100% homology. NYSDOH review ongoing -
-
PRESS RELEASE
Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I
Applied DNA Sciences intends to expand Linea™ Mpox Virus 1.0 Assay use to detect WHO-declared mpox Clade I. Validation studies underway for NYSDOH approval -
-
PRESS RELEASE
Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc. announces third quarter financial results for June 30, 2024, including operational highlights and future plans. Conference call/webcast today at 4:30 PM ET. View Form 10-Q at https://investors.adnas.com/sec-filings/ -
-
PRESS RELEASE
CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
Applied DNA Sciences, Inc. presents Linea IVT platform for enhanced mRNA production at 4th Annual mRNA-based Therapeutics Summit. Solution reduces dsRNA contamination, streamlines workflows, and boosts efficiency
